SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-079143
Filing Date
2023-07-07
Accepted
2023-07-07 16:30:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2320725d1_424b3.htm 424B3 14607
2 GRAPHIC image_001.jpg GRAPHIC 5535
  Complete submission text file 0001104659-23-079143.txt   23570
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-237736 | Film No.: 231077123
SIC: 2836 Biological Products, (No Diagnostic Substances)